Probable hemophagocytic lymphohistiocytosis by extensively drug‐resistant Salmonella Typhi
Cefdinir was started on day 9, however, on day 11, the patient had persistent fever and blood tests revealed thrombocytopenia. [...]she was referred to our hospital and admitted for suspected HLH (day 1 of hospitalization). On day 5 of hospitalization, antimicrobial susceptibility testing of the iso...
Gespeichert in:
| Veröffentlicht in: | Pediatric investigation 2022-01, Vol.64 (1), p.e14695-n/a |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 1 |
| container_start_page | e14695 |
| container_title | Pediatric investigation |
| container_volume | 64 |
| creator | Iwasaki, Tomoya Hara, Hideki Takahashi‐Igari, Miho Matsuda, Yasutoshi Imai, Hironori |
| description | Cefdinir was started on day 9, however, on day 11, the patient had persistent fever and blood tests revealed thrombocytopenia. [...]she was referred to our hospital and admitted for suspected HLH (day 1 of hospitalization). On day 5 of hospitalization, antimicrobial susceptibility testing of the isolate revealed resistance to ampicillin, trimethoprim-sulfamethoxazole, ciprofloxacin, azithromycin, and ceftriaxone, with susceptibility to meropenem (Table 1). XDR S. Typhi has acquired resistance to three first-line drugs (chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole), fluoroquinolones, and third-generation cephalosporins. 2 XDR S. Typhi has plasmid-encoding resistance elements (blaCTX-M-15 extended-spectrum β-lactamase) and carries the qnrS-fluoroquinolone-resistance gene. 2 Since November 2016, 339 XDR typhoid cases have been reported in Sindh, Pakistan. |
| doi_str_mv | 10.1111/ped.14695 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2577465565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2577465565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4055-a9c62922363a714698edf8937c0da0c3e59a447d54544f78de42a1d79d289d903</originalsourceid><addsrcrecordid>eNp9kc1KxDAYRYMo_owufAEpuNFFNUmTJlmK_yAoOIILIWSajI20TU1atTsfwWf0Scw4zkbQbBK-HA734wKwjeABiuewNfoAkVzQJbCOCMEphvB-Ob4zzFMOc7YGNkJ4ghByxskqWMsI5RhhtA4ebrybqEllktLUri3VoyuGzhZJNdRt6UobOjubuGBDMhkS89aZJtgXUw2J9v3j5_uHN_GvU02X3Kqqdo2pKpWMh7a0m2Blqqpgtn7uEbg7Ox0fX6RX1-eXx0dXaUEgpakSRY4FxlmeKTbbgxs95SJjBdQKFpmhQhHCNCWUkCnj2hCskGZCYy60gNkI7M29rXfPvQmdrG0oZjka4_ogMWWM5JTmNKK7v9An1_smppNRBjOBESP_U5wICFEMOwL7c6rwLgRvprL1tlZ-kAjKWTEyFiO_i4nszo-xn9RxuiAXTUTgcA682soMf5vkzenJXPkFeiaYEQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2884900136</pqid></control><display><type>article</type><title>Probable hemophagocytic lymphohistiocytosis by extensively drug‐resistant Salmonella Typhi</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Iwasaki, Tomoya ; Hara, Hideki ; Takahashi‐Igari, Miho ; Matsuda, Yasutoshi ; Imai, Hironori</creator><creatorcontrib>Iwasaki, Tomoya ; Hara, Hideki ; Takahashi‐Igari, Miho ; Matsuda, Yasutoshi ; Imai, Hironori</creatorcontrib><description>Cefdinir was started on day 9, however, on day 11, the patient had persistent fever and blood tests revealed thrombocytopenia. [...]she was referred to our hospital and admitted for suspected HLH (day 1 of hospitalization). On day 5 of hospitalization, antimicrobial susceptibility testing of the isolate revealed resistance to ampicillin, trimethoprim-sulfamethoxazole, ciprofloxacin, azithromycin, and ceftriaxone, with susceptibility to meropenem (Table 1). XDR S. Typhi has acquired resistance to three first-line drugs (chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole), fluoroquinolones, and third-generation cephalosporins. 2 XDR S. Typhi has plasmid-encoding resistance elements (blaCTX-M-15 extended-spectrum β-lactamase) and carries the qnrS-fluoroquinolone-resistance gene. 2 Since November 2016, 339 XDR typhoid cases have been reported in Sindh, Pakistan.</description><identifier>ISSN: 1328-8067</identifier><identifier>ISSN: 2096-3726</identifier><identifier>EISSN: 1442-200X</identifier><identifier>EISSN: 2574-2272</identifier><identifier>DOI: 10.1111/ped.14695</identifier><identifier>PMID: 34582121</identifier><language>eng</language><publisher>Australia: John Wiley & Sons, Inc</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Bacterial infections ; Blood tests ; Case reports ; Dengue fever ; Drug resistance ; hemophagocytic lymphohistiocytosis ; hemophagocytic syndrome ; Histiocytosis ; Hospitalization ; Humans ; Infections ; Informed consent ; Lymphatic diseases ; Lymphocytosis ; Lymphohistiocytosis, Hemophagocytic - diagnosis ; Lymphohistiocytosis, Hemophagocytic - drug therapy ; meropenem ; Microbial Sensitivity Tests ; Pediatrics ; Pharmaceutical Preparations ; Salmonella ; Salmonella enterica serovar Typhi ; Salmonella typhi ; Thrombocytopenia ; Tropical diseases ; Typhoid ; typhoid fever ; Typhoid Fever - complications ; Typhoid Fever - diagnosis ; Typhoid Fever - drug therapy</subject><ispartof>Pediatric investigation, 2022-01, Vol.64 (1), p.e14695-n/a</ispartof><rights>2021 Japan Pediatric Society</rights><rights>Copyright John Wiley & Sons, Inc. Jan/Dec 2022</rights><rights>2022 Japan Pediatric Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4055-a9c62922363a714698edf8937c0da0c3e59a447d54544f78de42a1d79d289d903</citedby><cites>FETCH-LOGICAL-c4055-a9c62922363a714698edf8937c0da0c3e59a447d54544f78de42a1d79d289d903</cites><orcidid>0000-0002-9341-2498</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fped.14695$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fped.14695$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,860,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34582121$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iwasaki, Tomoya</creatorcontrib><creatorcontrib>Hara, Hideki</creatorcontrib><creatorcontrib>Takahashi‐Igari, Miho</creatorcontrib><creatorcontrib>Matsuda, Yasutoshi</creatorcontrib><creatorcontrib>Imai, Hironori</creatorcontrib><title>Probable hemophagocytic lymphohistiocytosis by extensively drug‐resistant Salmonella Typhi</title><title>Pediatric investigation</title><addtitle>Pediatr Int</addtitle><description>Cefdinir was started on day 9, however, on day 11, the patient had persistent fever and blood tests revealed thrombocytopenia. [...]she was referred to our hospital and admitted for suspected HLH (day 1 of hospitalization). On day 5 of hospitalization, antimicrobial susceptibility testing of the isolate revealed resistance to ampicillin, trimethoprim-sulfamethoxazole, ciprofloxacin, azithromycin, and ceftriaxone, with susceptibility to meropenem (Table 1). XDR S. Typhi has acquired resistance to three first-line drugs (chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole), fluoroquinolones, and third-generation cephalosporins. 2 XDR S. Typhi has plasmid-encoding resistance elements (blaCTX-M-15 extended-spectrum β-lactamase) and carries the qnrS-fluoroquinolone-resistance gene. 2 Since November 2016, 339 XDR typhoid cases have been reported in Sindh, Pakistan.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Bacterial infections</subject><subject>Blood tests</subject><subject>Case reports</subject><subject>Dengue fever</subject><subject>Drug resistance</subject><subject>hemophagocytic lymphohistiocytosis</subject><subject>hemophagocytic syndrome</subject><subject>Histiocytosis</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Infections</subject><subject>Informed consent</subject><subject>Lymphatic diseases</subject><subject>Lymphocytosis</subject><subject>Lymphohistiocytosis, Hemophagocytic - diagnosis</subject><subject>Lymphohistiocytosis, Hemophagocytic - drug therapy</subject><subject>meropenem</subject><subject>Microbial Sensitivity Tests</subject><subject>Pediatrics</subject><subject>Pharmaceutical Preparations</subject><subject>Salmonella</subject><subject>Salmonella enterica serovar Typhi</subject><subject>Salmonella typhi</subject><subject>Thrombocytopenia</subject><subject>Tropical diseases</subject><subject>Typhoid</subject><subject>typhoid fever</subject><subject>Typhoid Fever - complications</subject><subject>Typhoid Fever - diagnosis</subject><subject>Typhoid Fever - drug therapy</subject><issn>1328-8067</issn><issn>2096-3726</issn><issn>1442-200X</issn><issn>2574-2272</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kc1KxDAYRYMo_owufAEpuNFFNUmTJlmK_yAoOIILIWSajI20TU1atTsfwWf0Scw4zkbQbBK-HA734wKwjeABiuewNfoAkVzQJbCOCMEphvB-Ob4zzFMOc7YGNkJ4ghByxskqWMsI5RhhtA4ebrybqEllktLUri3VoyuGzhZJNdRt6UobOjubuGBDMhkS89aZJtgXUw2J9v3j5_uHN_GvU02X3Kqqdo2pKpWMh7a0m2Blqqpgtn7uEbg7Ox0fX6RX1-eXx0dXaUEgpakSRY4FxlmeKTbbgxs95SJjBdQKFpmhQhHCNCWUkCnj2hCskGZCYy60gNkI7M29rXfPvQmdrG0oZjka4_ogMWWM5JTmNKK7v9An1_smppNRBjOBESP_U5wICFEMOwL7c6rwLgRvprL1tlZ-kAjKWTEyFiO_i4nszo-xn9RxuiAXTUTgcA682soMf5vkzenJXPkFeiaYEQ</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Iwasaki, Tomoya</creator><creator>Hara, Hideki</creator><creator>Takahashi‐Igari, Miho</creator><creator>Matsuda, Yasutoshi</creator><creator>Imai, Hironori</creator><general>John Wiley & Sons, Inc</general><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9341-2498</orcidid></search><sort><creationdate>202201</creationdate><title>Probable hemophagocytic lymphohistiocytosis by extensively drug‐resistant Salmonella Typhi</title><author>Iwasaki, Tomoya ; Hara, Hideki ; Takahashi‐Igari, Miho ; Matsuda, Yasutoshi ; Imai, Hironori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4055-a9c62922363a714698edf8937c0da0c3e59a447d54544f78de42a1d79d289d903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Bacterial infections</topic><topic>Blood tests</topic><topic>Case reports</topic><topic>Dengue fever</topic><topic>Drug resistance</topic><topic>hemophagocytic lymphohistiocytosis</topic><topic>hemophagocytic syndrome</topic><topic>Histiocytosis</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Infections</topic><topic>Informed consent</topic><topic>Lymphatic diseases</topic><topic>Lymphocytosis</topic><topic>Lymphohistiocytosis, Hemophagocytic - diagnosis</topic><topic>Lymphohistiocytosis, Hemophagocytic - drug therapy</topic><topic>meropenem</topic><topic>Microbial Sensitivity Tests</topic><topic>Pediatrics</topic><topic>Pharmaceutical Preparations</topic><topic>Salmonella</topic><topic>Salmonella enterica serovar Typhi</topic><topic>Salmonella typhi</topic><topic>Thrombocytopenia</topic><topic>Tropical diseases</topic><topic>Typhoid</topic><topic>typhoid fever</topic><topic>Typhoid Fever - complications</topic><topic>Typhoid Fever - diagnosis</topic><topic>Typhoid Fever - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwasaki, Tomoya</creatorcontrib><creatorcontrib>Hara, Hideki</creatorcontrib><creatorcontrib>Takahashi‐Igari, Miho</creatorcontrib><creatorcontrib>Matsuda, Yasutoshi</creatorcontrib><creatorcontrib>Imai, Hironori</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwasaki, Tomoya</au><au>Hara, Hideki</au><au>Takahashi‐Igari, Miho</au><au>Matsuda, Yasutoshi</au><au>Imai, Hironori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Probable hemophagocytic lymphohistiocytosis by extensively drug‐resistant Salmonella Typhi</atitle><jtitle>Pediatric investigation</jtitle><addtitle>Pediatr Int</addtitle><date>2022-01</date><risdate>2022</risdate><volume>64</volume><issue>1</issue><spage>e14695</spage><epage>n/a</epage><pages>e14695-n/a</pages><issn>1328-8067</issn><issn>2096-3726</issn><eissn>1442-200X</eissn><eissn>2574-2272</eissn><abstract>Cefdinir was started on day 9, however, on day 11, the patient had persistent fever and blood tests revealed thrombocytopenia. [...]she was referred to our hospital and admitted for suspected HLH (day 1 of hospitalization). On day 5 of hospitalization, antimicrobial susceptibility testing of the isolate revealed resistance to ampicillin, trimethoprim-sulfamethoxazole, ciprofloxacin, azithromycin, and ceftriaxone, with susceptibility to meropenem (Table 1). XDR S. Typhi has acquired resistance to three first-line drugs (chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole), fluoroquinolones, and third-generation cephalosporins. 2 XDR S. Typhi has plasmid-encoding resistance elements (blaCTX-M-15 extended-spectrum β-lactamase) and carries the qnrS-fluoroquinolone-resistance gene. 2 Since November 2016, 339 XDR typhoid cases have been reported in Sindh, Pakistan.</abstract><cop>Australia</cop><pub>John Wiley & Sons, Inc</pub><pmid>34582121</pmid><doi>10.1111/ped.14695</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-9341-2498</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1328-8067 |
| ispartof | Pediatric investigation, 2022-01, Vol.64 (1), p.e14695-n/a |
| issn | 1328-8067 2096-3726 1442-200X 2574-2272 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2577465565 |
| source | MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Anti-Bacterial Agents - therapeutic use Antibiotics Bacterial infections Blood tests Case reports Dengue fever Drug resistance hemophagocytic lymphohistiocytosis hemophagocytic syndrome Histiocytosis Hospitalization Humans Infections Informed consent Lymphatic diseases Lymphocytosis Lymphohistiocytosis, Hemophagocytic - diagnosis Lymphohistiocytosis, Hemophagocytic - drug therapy meropenem Microbial Sensitivity Tests Pediatrics Pharmaceutical Preparations Salmonella Salmonella enterica serovar Typhi Salmonella typhi Thrombocytopenia Tropical diseases Typhoid typhoid fever Typhoid Fever - complications Typhoid Fever - diagnosis Typhoid Fever - drug therapy |
| title | Probable hemophagocytic lymphohistiocytosis by extensively drug‐resistant Salmonella Typhi |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T12%3A14%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Probable%20hemophagocytic%20lymphohistiocytosis%20by%20extensively%20drug%E2%80%90resistant%20Salmonella%20Typhi&rft.jtitle=Pediatric%20investigation&rft.au=Iwasaki,%20Tomoya&rft.date=2022-01&rft.volume=64&rft.issue=1&rft.spage=e14695&rft.epage=n/a&rft.pages=e14695-n/a&rft.issn=1328-8067&rft.eissn=1442-200X&rft_id=info:doi/10.1111/ped.14695&rft_dat=%3Cproquest_cross%3E2577465565%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2884900136&rft_id=info:pmid/34582121&rfr_iscdi=true |